Background In the 5 years that have passed since the publication of the 2018 International
Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR‐Allergic Rhinitis …

Allergen immunotherapy is a cornerstone in the treatment of allergic children. The clinical
efficiency relies on a well‐defined immunologic mechanism promoting regulatory T cells and …

Allergic rhinoconjunctivitis (AR) is an allergic disorder of the nose and eyes affecting about a
fifth of the general population. Symptoms of AR can be controlled with allergen avoidance …

Allergen immunotherapy (AIT) has been in use for the treatment of allergic disease for more
than 100 years. Asthma treatment relies mainly on corticosteroids and other controllers …

Background: The persistently high prevalence of allergic diseases in Western industrial
nations and the limited possibilities of causal therapy make evidence-based …

Background Allergen immunotherapy (AIT) is the only causal treatment for respiratory
allergy. Long-term real-life effectiveness of AIT remains to be demonstrated beyond the …

The improvement of the knowledge of the pathophysiological mechanisms underlying the
tolerance and sensitization to food antigens has recently led to a radical change in the …

Allergen immunotherapy (AIT) is a proven therapeutic option for the treatment of allergic
rhinitis and/or asthma. Many guidelines or national practice guidelines have been produced …

Atopic dermatitis (AD) is characterized by pruritus, barrier disruption, and
inflammationincluding type 2 cytokine production. Interleukin-33 (IL-33) is an inflammatory …

One hundred and ten years after Noon's first clinical report of the subcutaneous application
of allergen extracts, allergen immunotherapy (AIT) has evolved as the most important pillar …